The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The Association Between Diabetes Metabolic Control and Drug Adherence in an Indigent Population
Open accessAbstract
OBJECTIVE—Studies of the association between diabetes metabolic control and adherence to drug therapy have yielded conflicting results. Because low socioeconomic and minority populations have poorer diabetes outcomes and greater barriers to adherence, we examined the relationship between adherence and diabetes metabolic control in a large indigent population. RESEARCH DESIGN AND METHODS—The study population consisted of patients receiving medical care from a university-based internal medicine clinic serving a low-income population in rural central Virginia. The sample comprised 810 patients with type 2 diabetes who received oral diabetes medications from the clinic pharmacy and had at least one HbA1c determination during the study period. Multiple linear regression was used to examine the association of HbA1c level as well as change in HbA1c level with medication adherence, demographic, and clinical characteristics. RESULTS—Better metabolic control was independently associated with greater medication adherence, increasing age, white (versus African-American) race, and lower intensity of drug therapy. For each 10% increment in drug adherence, HbA1c decreased by 0.16% (P < 0.0001). Controlling for other demographic and clinical variables, the mean HbA1c of African-Americans was 0.29% higher than that of whites (P = 0.04). Additionally, the intensity of diabetes drug therapy for African-Americans was lower, as was their measured adherence to it. There was no association between metabolic control and gender, income, encounter frequency, frequency of HbA1c testing, or continuity of care. CONCLUSIONS—Adherence to medication regimens for type 2 diabetes is strongly associated with metabolic control in an indigent population; African-Americans have lower adherence and worse metabolic control. Greater efforts are clearly needed to facilitate diabetes self-management behaviors of low-income populations and foster culturally sensitive and appropriate care for minority groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While following treatment regimens consistently improves A1C (9–12), the impact is modest.”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Race, Gender, and Partnership in the Patient-Physician Relationship
Cooper, L. A. (1999) · JAMA · doi:10.1001/jama.282.6.583 · Cited by 2,161
LaVeist, T. A., Nickerson, K. J., & Bowie, J. V. (2000) · Medical Care Research and Review · doi:10.1177/1077558700057001s07 · Cited by 918
Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
Haynes, R. B., McKibbon, K. A., & Kanani, R. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01073-2 · Cited by 643
Cited by
Sorted by citations
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Young-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
Cramer, J. A., Benedict, Á., Muszbek, N., Keskinaslan, A., & Khan, Z. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01630.x · Cited by 488
What are validated self-report adherence scales really measuring?: a systematic review
Nguyen, T., Caze, A. L., & Cottrell, N. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12194 · Cited by 431
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus
Rubin, R. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.04.012 · Cited by 403
Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall, M., Williams, L. K., Potts, L. A., Divine, G., Xi, H., & Lafata, J. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2800 · Cited by 404
Gonzalez, J. S., Tanenbaum, M. L., & Commissariat, P. V. (2016) · American Psychologist · doi:10.1037/a0040388 · Cited by 354
Patient Adherence Improves Glycemic Control
Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El‐Kebbi, I. M., Gallina, D. L., Barnes, C., & Phillips, L. S. (2005) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721705274927 · Cited by 339
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 317
Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review
Walker, R. J., Smalls, B. L., Campbell, J. A., Williams, J. L. S., & Egede, L. E. (2014) · Endocrine · doi:10.1007/s12020-014-0195-0 · Cited by 308
Problems Paying Out-of-Pocket Medication Costs Among Older Adults With Diabetes
Piette, J. D., Heisler, M., & Wagner, T. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.384 · Cited by 301
Bains, S. S., & Egede, L. E. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0160 · Cited by 311
Medication Adherence and Associated Hemoglobin A 1c in Type 2 Diabetes
Krapek, K. J., KING, K. B., Warren, S. S., George, K. G., Caputo, D. A., Mihelich, K., Holst, E. M., Nichol, M. B., Shi, S., Livengood, K., et al. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d612 · Cited by 287
Medication Taking and Diabetes
Odegard, P. S., & Capoccia, K. L. (2007) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707308407 · Cited by 274
Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.004 · Cited by 262
Oral antidiabetic medication adherence and glycemic control in managed care.
Rozenfeld, Y., Hunt, J. S., Plauschinat, C. A., & Wong, K. S. (2008) · PubMed · Cited by 257
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012) · Europe PMC (PubMed Central) · Cited by 246
Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study
Tiv, M., Viel, J.-F., Mauny, F., Eschwège, E., Weill, A., Fournier, C., Fagot-Campagna, A., & Penfornis, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032412 · Cited by 245
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Hur, K. Y., Moon, M. K., Park, J. S., Kim, S., Lee, S., Yun, J., Baek, J. H., Noh, J., Lee, B., Oh, T. J., et al. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0156 · Cited by 233
Vervloet, M., van Dijk, L., Santen-Reestman, J., van Vlijmen, B., van Wingerden, P., Bouvy, M. L., & de Bakker, D. H. (2012) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2012.05.005 · Cited by 215
Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes
Al-Qazaz, H., Sulaiman, S. A. S., Hassali, M. A., Shafie, A. A., Sundram, S., Al-Nuri, R., & Saleem, F. (2011) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-011-9582-2 · Cited by 226
Marshall, M. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028274 · Cited by 215
Mayer-Davis, E. J., D'Antonio, A. M., Smith, S. M., Kirkner, G., Levin Martin, S., Parra-Medina, D., & Schultz, R. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.10.1736 · Cited by 202
Medication Nonadherence in Diabetes
Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D. (2012) · Diabetes Care · doi:10.2337/dc12-0572 · Cited by 195
Gellad, W. F., Haas, J. S., & Safran, D. G. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0385-z · Cited by 181
Diabetes Burden and Diabetes Distress: the Buffering Effect of Social Support
Baek, R. N., Tanenbaum, M. L., & Gonzalez, J. S. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9585-4 · Cited by 203
Alcohol consumption is inversely associated with adherence to diabetes self‐care behaviours
Ahmed, A., Karter, A. J., & Liu, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01878.x · Cited by 171
Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence
Williams, L. K., Joseph, C. L. M., Peterson, E. L., Wells, K. E., Wang, M., Chowdhry, V. K., Walsh, M., Campbell, J., Rand, C. S., Apter, A. J., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.020 · Cited by 165
Wabe, N., Angamo, M. T., & Hussein, S. (2011) · North American Journal of Medicine and Science · doi:10.4297/najms.2011.3418 · Cited by 192
Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus
Odegard, P. S., & Gray, S. L. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708320558 · Cited by 152
Sakthong, P., Chabunthom, R., & Charoenvisuthiwongs, R. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l453 · Cited by 151
Appointment Adherence and Disparities in Outcomes Among Patients with Diabetes
Schectman, J. M., Schorling, J. B., & Voss, J. D. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0747-1 · Cited by 151
Self-citationLongitudinal effects of medication nonadherence on glycemic control
Egede, L. E., Gebregziabher, M., Echols, C., & Lynch, C. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014526362 · Cited by 146
Dick, J. J., Nundy, S., Solomon, M. C., Bishop, K. N., Chin, M. H., & Peek, M. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500534 · Cited by 126
The Influence of Insulin Use on Glycemic Control
Cramer, J. A., & Pugh, M. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.78 · Cited by 134
Kamuhabwa, A. A. R., & Charles, E. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s68786 · Cited by 134
Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control
Tan, M. Y., & Magarey, J. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.03.017 · Cited by 134
The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control
Mayberry, L. S., Gonzalez, J. S., Wallston, K. A., Kripalani, S. B., & Osborn, C. Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.010 · Cited by 136
Medication Adherence and Racial Differences in A1C Control
Adams, A. S., Trinacty, C. M., Zhang, F., Kleinman, K., Grant, R. W., Meigs, J. B., Soumerai, S. B., & Ross‐Degnan, D. (2008) · Diabetes Care · doi:10.2337/dc07-1924 · Cited by 127
Kuo, Y., Raji, M. A., Markides, K. S., Ray, L. A., Espino, D. V., & Goodwin, J. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3054 · Cited by 124
Medication adherence and glycemic control among newly diagnosed diabetes patients
Lin, L.-K., Sun, Y., Heng, B. H., Chew, D. E. K., & Chong, P.-N. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000429 · Cited by 123
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Kim, N. H., Seo, J. A., Kim, M. K., Lim, J. H., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0282 · Cited by 130
Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors.
Kalyango, J. N., Owino, E., & Nambuya, A. P. (2008) · PubMed Central · Cited by 116
Factors related to patient adherence to antidiabetic drug therapy
Gimenes, H. T., Zanetti, M. L., & Haas, V. J. (2009) · Revista Latino-Americana de Enfermagem · doi:10.1590/s0104-11692009000100008 · Cited by 114
Pawaskar, M. D., CAMACHO, F. T., Anderson, R. T., Cobden, D., Joshi, A. V., & Balkrishnan, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.007 · Cited by 111
Vervloet, M., van Dijk, L., Santen-Reestman, J., van Vlijmen, B., Bouvy, M. L., & de Bakker, D. H. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-5 · Cited by 108
Developing a behavioral model for mobile phone-based diabetes interventions
Nundy, S., Dick, J. J., Solomon, M. C., & Peek, M. E. (2012) · Patient Education and Counseling · doi:10.1016/j.pec.2012.09.008 · Cited by 115
Validity of Medication Adherence Self-Reports in Adults With Type 2 Diabetes
Gonzalez, J. S., Schneider, H. E., Wexler, D. J., Psaros, C., Delahanty, L. M., Cagliero, E., & Safren, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0410 · Cited by 106
Lawerence, D. B., Ragucci, K. R., Long, L. B., Parris, B. S., & Helfer, L. A. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.6.466 · Cited by 102
Marinho, F. D. S., Moram, C. B. D. M., Rodrigues, P. C., Leite, N. C., Salles, G. F., & Cardoso, C. R. L. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8970196 · Cited by 105
Kreyenbuhl, J. A., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., & Valenstein, M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn106 · Cited by 101
Schlenk, E. A., Dunbar-Jacob, J., & Engberg, S. (2004) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-20040701-08 · Cited by 95
Differing Effects of Metformin on Glycemic Control by Race-Ethnicity
Williams, L. K., Padhukasahasram, B., Ahmedani, B. K., Peterson, E. L., Wells, K. E., Burchard, E. G., & Lanfear, D. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1539 · Cited by 96
Barriers to Adult Hemodialysis Patients' Self-Management of Oral Medications
Browne, T. A., & Merighi, J. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.002 · Cited by 93
Patient and Physician Factors Associated With Adherence to Diabetes Medications
Schoenthaler, A., Schwartz, B. S., Wood, C., & Stewart, W. F. (2012) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721712440333 · Cited by 92
Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt
Shams, M. E. E., & Barakat, E. A. M. E. (2010) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2010.07.004 · Cited by 92
Racial Differences in Glycemic Control in a Well-Functioning Older Diabetic Population
de Rekeneire, N., Rooks, R. N., Simonsick, E. M., Shorr, R. I., Kuller, L. H., Schwartz, A. V., & Harris, T. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.1986 · Cited by 92
Alqarni, A. M., Alrahbeni, T. M. A., AlQarni, A. M., & Qarni, H. M. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s176355 · Cited by 106
Cobden, D., Lee, W. C., Balu, S., Joshi, A. V., & Pashos, C. L. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.948 · Cited by 90
Clinical inertia in general practice: widespread and related to the outcome of diabetes care
van Bruggen, R., Gorter, K. J., Stolk, R. P., Klungel, O. H., & Rutten, G. E. H. M. (2009) · Family Practice · doi:10.1093/fampra/cmp053 · Cited by 90
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
Rennard, S. I., Bantje, T. A., Centanni, S., Chanez, P., Чучалин, А. Г., D’Urzo, A. D., Kornmann, O., Perry, S., Jack, D., Owen, R. J., et al. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.02.001 · Cited by 89
Cheong, C., Barner, J. C., Lawson, K. A., & Johnsrud, M. T. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.10.003 · Cited by 91
Vermeire, E., Hearnshaw, H., Rätsep, A., Levasseur, G., Petek, D., van Dam, H. A., van der Horst, F. G., Vinter-Repalust, N., Wens, J., Dale, J., et al. (2007) · Primary Care Diabetes · doi:10.1016/j.pcd.2006.07.002 · Cited by 105
Rwegerera, G. M. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.17.252.2972 · Cited by 86
Medication Adherence and Diabetes Control in Urban African Americans With Type 2 Diabetes.
Hill‐Briggs, F., Gary‐Webb, T. L., Bone, L., Hill, M. N., Levine, D. M., & Brancati, F. L. (2005) · Health Psychology · doi:10.1037/0278-6133.24.4.349 · Cited by 83
Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents
Kalsekar, I. D., Madhavan, S., Amonkar, M. M., Makela, E. H., Scott, V., Douglas, S. M., & Elswick, B. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g606 · Cited by 83
Adisa, R., Alutundu, M. B., & Fakeye, T. O. (2009) · Pharmacy Practice · doi:10.4321/s1886-36552009000300006 · Cited by 84
Socio‐economic status and HbA 1c in type 2 diabetes: A systematic review and meta‐analysis
Bijlsma-Rutte, A., Rutters, F., Elders, P. J. M., Bot, S. D. M., & Nijpels, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3008 · Cited by 82
Guillausseau, P.-J. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70011-3 · Cited by 82
Vanderpoel, D. R., Hussein, M. A., Watson-Heidari, T., & Perry, A. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.018 · Cited by 82
Williams, L. K., Peterson, E. L., Wells, K. E., Campbell, J., Wang, M., Chowdhry, V. K., Walsh, M., Enberg, R. N., Lanfear, D. E., & Pladevall, M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.034 · Cited by 80
Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study
Shah, N. R., Hirsch, A. G., Zacker, C., Taylor, S. D., Wood, G. C., & Stewart, W. F. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0870-z · Cited by 81
Adisa, R., Fakeye, T., & Fasanmade, A. (2011) · Pharmacy in practice · doi:10.4321/s1886-36552011000200003 · Cited by 80
Egede, L. E., Gebregziabher, M., Hunt, K. J., Axon, R. N., Echols, C. L., Gilbert, G. E., & Mauldin, P. D. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p442 · Cited by 80
Hearnshaw, H., & Lindenmeyer, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01783.x · Cited by 80
Feldman, B. S., Cohen-Stavi, C. J., Leibowitz, M., Hoshen, M. B., Singer, S. R., Bitterman, H., Lieberman, N., & Balicer, R. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108145 · Cited by 79
Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids
Williams, L. K., Joseph, C. L. M., Peterson, E. L., Moon, C., Xi, H., Krajenta, R. J., Johnson, R., Wells, K. E., Booza, J. C., Tunceli, K., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.029 · Cited by 79
Chatterjee, S., Byun, J., Dutta, K., Pedersen, R. U., Pottathil, A., & Xie, H. (2018) · European Journal of Information Systems · doi:10.1080/0960085x.2018.1485619 · Cited by 83
Beyhaghi, H., Reeve, B. B., Rodgers, J. E., & Stearns, S. C. (2016) · Value in Health · doi:10.1016/j.jval.2016.07.001 · Cited by 75
Schweizer, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2503 · Cited by 77
Measurements of medication adherence in diabetic patients with poorly controlled HbA1c
Cohen, H. W., Shmukler, C., Ullman, R. F., Rivera, C., & Walker, E. A. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02898.x · Cited by 74
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81
Food Insecurity and Health: A Conceptual Framework
Weiser, S. D., Palar, K., Hatcher, A. M., Young, S. L., Frongillo, E. A., & Laraia, B. A. (2015) · CRC Press eBooks · doi:10.1201/b18451-3 · Cited by 73
Effect of a medication copayment increase in veterans with schizophrenia.
Zeber, J. E., Grazier, K. L., Valenstein, M. M., Blow, F. C., & Lantz, P. M. (2007) · PubMed · Cited by 73
Patients’ Beliefs and Preferences Regarding Doctors’ Medication Recommendations
Goff, S. L., Mazor, K. M., Meterko, V., Dodd, K., & Sabin, J. E. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0470-3 · Cited by 72
Huang, Y., Shiyanbola, O. O., & Chan, H. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.06.010 · Cited by 72
Challenges of Treatment Adherence in Older Patients with Parkinson’s Disease
Bainbridge, J. L., & Ruscin, J. M. (2009) · Drugs & Aging · doi:10.2165/0002512-200926020-00006 · Cited by 68
Mukherjee, S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5352.2876 · Cited by 66
Settineri, S., Frisone, F., Merlo, E. M., Geraci, D., & Martino, G. (2019) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s193752 · Cited by 91
Vervloet, M., van Dijk, L., de Bakker, D. H., Souverein, P. C., Santen-Reestman, J., van Vlijmen, B., van Aarle, M. C. W., van der Hoek, L. S., & Bouvy, M. L. (2014) · Diabetic Medicine · doi:10.1111/dme.12439 · Cited by 65
Kardas, P. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00462.x · Cited by 64
Peeters, B., Tongelen, I. V., Boussery, K., Mehuys, E., Remon, J. P., & Willems, S. J. T. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03133.x · Cited by 67
Shiyanbola, O. O., Brown, C. M., & Ward, E. C. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s152146 · Cited by 62
Jaam, M., Ibrahim, M. I. M., Kheir, N., & Awaisu, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.015 · Cited by 62
Wang, Y., Lee, J. W. N., Toh, M. P. H., Tang, W. E., & Ko, Y. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03733.x · Cited by 61
Refill adherence and polypharmacy among patients with type 2 diabetes in general practice
van Bruggen, R., Gorter, K. J., Stolk, R. P., Zuithoff, N. P. A., Klungel, O. H., & Rutten, G. E. H. M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1810 · Cited by 61
Patients' Adherence to Anti-Diabetic Medications in a Hospital at Ajman, UAE.
Arifulla, M., John, L. J., Sreedharan, J., Muttappallymyalil, J., & Basha, S. A. (2014) · Europe PMC (PubMed Central) · Cited by 60
Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes
Hankó, B., Kázmér, M., Kumli, P., Hrágyel, Z., Samu, A., Vincze, Z., & Zelkó, R. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9070-2 · Cited by 60
The association between the measurement of adherence to anti-diabetes medicine and the HbA1c
Doggrell, S. A., & Warot, S. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9929-6 · Cited by 59
Metadata
- Authors
- Schectman, J. M., Nadkarni, M. M., & Voss, J. D.
- Affiliations
- University of Virginia (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-06-01
- Volume
- 25
- Issue
- 6
- Pages
- 1015-1021
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2148382332
- Cited by
- 373
- References
- 54
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 19 · 2021: 12 · 2020: 15 · 2019: 7 · 2018: 12 · 2017: 18 · 2016: 15 · 2015: 17 · 2014: 26 · 2013: 14 · 2012: 28
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, medication adherence, glycemic control, HbA1c, low-income populations, African Americans, racial disparities, socioeconomic status, oral antidiabetic drugs, diabetes self-management, minority health, rural health care
- MeSH terms
- Black or African American, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Income, Male, Middle Aged, Patient Compliance, Poverty, Regression Analysis, Virginia, Multivariate Analysis, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review